COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 2049: Articles 20481-20490  | Next

Meta-analysis of the SARS-CoV-2 serial interval and the impact of parameter uncertainty on the COVID-19 reproduction number
Challen, R., Brooks-Pollock, E., Tsaneva-Atanasova, K., Danon, L.
10.1101/2020.11.17.20231548 — Posted: 2020-11-18
An efficient distributed algorithm with application to COVID-19 data from heterogeneous clinical sites
Tong, J., Luo, C., Islam, M. N., Sheils, N., Buresh, J., Edmondson, M., Merkel, P. A., Lautenbach, E., Duan, R., Chen, Y.
10.1101/2020.11.17.20220681 — Posted: 2020-11-18
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Chioh, F. W., Fong, S.-W., Young, B., Wu, K.-X., Siau, A., Krishnan, S., Chan, Y.-H., Teo, L. L., Gao, F., Tan, R. S., Zhong, L., Koh, A. S., Tan, S. Y., Tambyah, P. A., Renia, L., Ng, L. F. P., Lye, D. C. B., Cheung, C.
10.1101/2020.11.16.20232835 — Posted: 2020-11-18
RT-LAMP assay for ultra-sensitive detection of SARS-CoV-2 in saliva and VTM clinical samples
Ganguli, A., Mostafa, A., Berger, J., Stewart de Ramirez, S. A., Baltaji, A., Roth, K., Aamir, M., Aedma, S., Mady, M., Mahajan, P., Sathe, S., Johnson, M., White, K., Kumar, J., Valera, E., Bashir, R.
10.1101/2020.11.16.20232678 — Posted: 2020-11-18
Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials
Izcovich, A., Siemieniuk, R., Bartoszko, J. J., Ge, L., Zeraatkar, D., Kum, E., Khamis, A. M., Rochwerg, B., Agoritsas, T., Chu, D. K., McLeod, S. L., Mustafa, R. A., Vandvik, P. O., Brignardello-Petersen, R.
10.1101/2020.11.16.20232876 — Posted: 2020-11-18
Effectiveness of Second Wave COVID-19 Response Strategies in Australia
Milne, G. J., Xie, S., Poklepovich, D., O'Halloran, D., Yap, M., Whyatt, D.
10.1101/2020.11.16.20232843 — Posted: 2020-11-18
Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in five localities in an Indian metropolitan city
Ghose, A., Bhattacharya, S., Karthikeyan, A. S., Kudale, A. M., Monteiro, J. M., Joshi, A., Medigeshi, G. R., Kang, G., Bal, V., Rath, S., Shashidhara, L. S., John, J., Chaudhuri, S., Nagarkar, A.
10.1101/2020.11.17.20228155 — Posted: 2020-11-18 Discussion: Onsite
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks
Snell, L. B., Fisher, C. L., Taj, U., Merrick, B., Alcolea-Medina, A., Charalampous, T., Signell, A. W., Wilson, H. D., Betancor, G., Tan Kia Ik, M., Cunningham, E., Cliff, P. R., Pickering, S., Galao, R. P., Batra, R., Neil, S. J. D., Malim, M. H., Doores, K. J., Douthwaite, S. T., Nebbia, G., Edgeworth, J. D., Awan, A. R., The COVID-19 Genomics UK (COG-UK) consortium
10.1101/2020.11.17.20232827 — Posted: 2020-11-18
Immune memory in mild COVID-19 patients and unexposed donors from India reveals persistent T cell responses after SARS-CoV-2 infection
Ansari, A., Arya, R., Sachan, S., Jha, S. N., Kalia, A., Lall, A., Sette, A., Grifoni, A., Weiskopf, D., Coshic, P., Sharma, A., Gupta, N.
10.1101/2020.11.16.20232967 — Posted: 2020-11-18
Scientific output on coronavirus and WHO's Solidarity Project: a science-based choice?
Galina, A. C., Sarzi, D. S., Medeiros, L. C. d., Sampaio, A. L. F., Leta, J.
10.1101/2020.11.16.20232488 — Posted: 2020-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).